A major advance in cancer study is occurring with the use of VHH fragments to re-engage dysfunctional p53. This essential cancer suppressor protein is frequently lost in various kinds of malignancies, resulting https://nanobookmarking.com/story21845204/mini-antibodies-reactivate-the-p53-protein-the-potential-pathway-for-tumor-therapy